Advances in Interventional Cardiology
eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2025
vol. 21
 
Share:
Share:
abstract:
Original paper

Comparative prognostic performance of the FIB-4 index versus SYNTAX and GRACE scores in predicting major cardiovascular events in acute coronary syndrome

Dogac Oksen
1
,
Muhammed H. Gecit
2
,
Zubeyir Bulat
3
,
Mehmet E. Gokce
2
,
Mehmet E. Bilgin
2
,
Sahra Balcioglu
2
,
Sukru Arslan
2
,
Veysel Oktay
2

  1. Medical Faculty, Altınbaş University, Istanbul, Turkey
  2. Institute of Cardiology, Istanbul University Cerrahpasa, Istanbul, Turkey
  3. Şırnak State Hospital, Sirnak, Turkey
Adv Interv Cardiol 2025; 21, 3 (81): 332–340
Online publish date: 2025/08/31
View full text Get citation
 
Introduction:
The Fibrosis-4 (FIB-4) index, a non-invasive marker of liver fibrosis originally developed for non-alcoholic fatty liver disease (NAFLD), has gained attention for its prognostic value in cardiovascular disease.

Aim:
Given the shared metabolic risk between NAFLD and acute coronary syndrome (ACS), this study aimed to evaluate the association between FIB-4 and major adverse cardiovascular events (MACE) in patients with ACS, in comparison with conventional risk scores.

Material and methods:
This is an observational cohort study included 941 patients hospitalized with ACS between 2017 and 2021. Patients were classified into three FIB-4 categories: low, < 1.45; intermediate, 1.45–3.25; and high, ≥ 3.25. Clinical, laboratory, angiographic, and echocardiographic data were collected. MACE incidence was evaluated over a median follow-up of 67.5 months. Cox regression and receiver operating characteristic (ROC) analyses were performed.

Results:
MACE occurred in 37.9% of patients in the high FIB-4 group, compared to 28.7% and 29.2% in the low and intermediate groups, respectively (p = 0.046). FIB-4 was an independent predictor of MACE (hazard ratio [HR]: 1.547; 95% CI: 1.169–2.046; p = 0.002). ROC analysis demonstrated superior prognostic accuracy for FIB-4 (area under the ROC curve: 0.693) over SYNTAX (0.609) and GRACE (0.552) scores. A Kaplan-Meier analysis showed significantly lower survival in the high FIB-4 group (p = 0.007).

Conclusions:
The FIB-4 index is a robust, accessible predictor of adverse cardiovascular outcomes in ACS and may enhance conventional risk stratification strategies by integrating systemic metabolic burden into cardiovascular risk assessment.

keywords:

fibrosis, acute coronary syndrome, non-alcoholic fatty liver disease, risk, coronary artery disease

Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.